Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues

Published:2016 Issue:2 Volume:19 Page:148
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Damavandi Zahra¹,Torkashvand Safoora²³,Vasei Mohammad⁴,Soltani Bahram M.¹,Tavallaei Mahmood⁵,Mowla Seyed Javad¹

Affiliation:

1. Department of Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.

2. Department of Genetics, Faculty of Biological Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran.

3. Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.

4. Pathology Laboratory, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

5. Human Genetic Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

Publisher

Korean Breast Cancer Society

Subject

Cancer Research,Oncology

Link

http://synapse.koreamed.org/pdf/10.4048/jbc.2016.19.2.148

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensemble‐based classification using microRNA expression identifies a breast cancer patient subgroup with an ultralow long‐term risk of metastases;Cancer Medicine;2024-04-27

2. Exosome microRNA-22 inhibiting proliferation, migration and invasion through regulating Twist1/CADM1 axis in osteosarcoma;Scientific Reports;2024-01-08

3. lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases;Epigenomics;2023-12

4. miR-22 original mesenchymal stem cells exosome regulate Twist1/CADM1 Axis inhibiting proliferation, migration and invasion in osteosarcoma;2023-08-21

5. Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives;Molecular Therapy - Oncolytics;2023-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3